$92.560
+5.517 (+5.96%)收盤時
HNGE 資訊
HNGE 事件
Company Raises Revenue Guidance to $856M-$860M
The company said, "We are raising our revenue guidance to be between $856 million and $860 million, reflecting year-over-year growth of 46% at the midpoint. We are raising our non-GAAP income from operations guidance to be between $236 million and $244 million, reflecting year-over-year growth of 101% and non-GAAP operating margin of 28% at the midpoint."
Hinge Health Reports $213M Revenue, Acquires Cylinder Health
Reports revenue $213M, consensus $201.49M. "We delivered another strong quarter ahead of expectations, generating $213 million in revenue with 53% year-over-year growth, while more than tripling free cash flow from a year ago. This quarter's outperformance was driven by continued high member conversion and reflects our ability to deliver a great experience, improve member outcomes and lower client costs," said Daniel Perez, Co-Founder and CEO, Hinge Health. "We also announced the acquisition of Cylinder Health today, marking our entry into gastrointestinal care. Combined with the strength of our core musculoskeletal care programs and the rapid adoption of our Migraine Care Program, our expansion into GI is another step toward our vision of building a durable, multi-condition platform to automate the delivery of care. Building on this momentum, we're raising our revenue and profitability expectations for the remainder of 2026, and are confident in our trajectory for 2027."
Company Expects Revenue Between $223M and $225M
The company said, "We expect revenue to be between $223 million and $225 million, reflecting year-over-year growth of 45% at the midpoint. We expect non-GAAP income from operations to be between $61 million and $63 million, reflecting year-over-year growth of 104% and non-GAAP operating margin of 28% at the midpoint."
Board Approves Share Repurchase Program Totaling $496.5 Million
On November 10, 2025, our board of directors approved a share repurchase program with authorization to purchase up to $250 million of our Class A common stock. As of July 29, 2026, we had repurchased an aggregate of $196.5 million of our Class A common stock under the program. On July 29, 2026, our board of directors approved an increase to the program, resulting in $300.0 million of our Class A common stock available for future repurchase, for a total aggregate amount authorized under the program of $496.5 million as of such date.
Hinge Health Acquires Cylinder Health for $105 Million
Hinge Health announced that it has signed a definitive agreement to acquire Cylinder Health, Inc, a leader in virtual-first digestive healthcare, for $105 million in cash consideration. With this acquisition, Hinge Health intends to launch an integrated Gastrointestinal (GI) Care Program to complement its existing Musculoskeletal (MSK) and Migraine Care Programs. "We're entering GI care because of member and client demand," said Daniel Perez, Co-Founder and CEO of Hinge Health. "Many people we already serve for back, joint, pelvic, and migraine care also have chronic digestive conditions. After spending time with Terry Boch and the Cylinder team, it's clear that Cylinder gives us a running start in a category with significant unmet need." The acquisition is subject to customary closing conditions. It is expected to close in the third quarter of 2026.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。